Systolic blood pressure as a potential target of sigma‐1 receptor agonist therapy

E-ISSN： 1751-7176|20|2|416-417

ISSN： 1524-6175

Source： The Journal of Clinical Hypertension, Vol.20, Iss.2, 2018-02, pp. : 416-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does Systolic Blood Pressure Response to Lifestyle Intervention Indicate Metabolic Risk and Health‐Related Quality‐of‐Life Improvement Over 1 Year?

The Journal of Clinical Hypertension, Vol. 17, Iss. 5, 2015-05 ,pp. : 375-380

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systolic Blood Pressure Can Be Lowered by Strict Volume Control in Hemodialysis Patients

The Journal of Clinical Hypertension, Vol. 15, Iss. 8, 2013-08 ,pp. : 607-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do thiazide diuretics reduce central systolic blood pressure in hypertension?

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 133-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated Diastolic, But Not Systolic, Blood Pressure Measured in the Emergency Department Predicts Future Development of Hypertension in Normotensive Individuals

The Journal of Clinical Hypertension, Vol. 17, Iss. 5, 2015-05 ,pp. : 359-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aldosterone: Yet Another Path to Blood Pressure Variability and Target Organ Damage

The Journal of Clinical Hypertension, Vol. 17, Iss. 8, 2015-08 ,pp. : 609-610

John Wiley & Sons Inc

Access to resources Recommend Favorite